John P. Saharek
CIK: 0001632091
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HROW
HARROW, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 7, 2025HROW
HARROW, INC.
Tax Payment(F)Direct109.5K shares at avg. $23.09$2.5M - Apr 3, 2025HROW
HARROW, INC.
Exercise(M)Direct277.2K shares- - Sep 11, 2024HROW
HARROW, INC.
Exercise(M)Direct90K shares at avg. $7.37$663K - Sep 11, 2024HROW
HARROW, INC.
Tax Payment(F)Direct45.1K shares at avg. $41.37$1.9M
1-4 of 4 transactions
About SAHAREK JOHN P.
SAHAREK JOHN P. (SEC CIK 0001632091) files insider reports with the SEC as CEO of ImprimisRx of HARROW, INC. (HROW).
Signal8 holds 2 ownership filings by SAHAREK JOHN P., all Form 4s, filed between Sep 13, 2024 and Apr 7, 2025. Those filings report 4 transactions, from Sep 11, 2024 to Apr 7, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on SAHAREK JOHN P.'s filings is in NASHVILLE, TN.
Recent filings by SAHAREK JOHN P.
Other insiders filing for HARROW, INC. (HROW)
- Shojaei Amir, CHIEF SCIENTIFIC OFFICER
- Sternberg Perry J., Director
- SILVERNAIL LAUREN P, Director
- Graves Adrienne L, Director
- BAUM MARK L, CHIEF EXECUTIVE OFFICER
- BOLL ANDREW R., PRESIDENT AND CFO